The present application describes modulators of MCP-1 of formula (I): ##STR00001## or pharmaceutically acceptable salt forms thereof, useful for the prevention of asthma, multiple sclerosis, artherosclerosis, and rheumatoid arthritis.
Web www.patentalert.com
< Use of ramoplanin to treat diseases associated with the use of antibiotics
> Sialic acid nucleotide sugars
HOME | NEW USER | LOGIN | SUBSCRIPTIONS | SEARCH | GUESTBOOK | CONTACT